MOH

What the Smart Investors Know About Molina Healthcare

Shares of Molina Healthcare have moved 1.2% today, and are now trading at a price of $367.72. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 274,682 compared to the stock's average volume of 365,419.

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. Based in Long Beach, United States the company has 15,000 full time employees and a market cap of $21,438,076,928.

The company is now trading 1.15% away from its average analyst target price of $363.54 per share. The 13 analysts following the stock have set target prices ranging from $315.0 to $417.0, and on average give Molina Healthcare a rating of hold.

Over the last 52 weeks, MOH stock has risen 8.0%, which amounts to a -10.0% difference compared to the S&P 500. The stock's 52 week high is $372.0 whereas its 52 week low is $256.19 per share. With its net margins declining an average -5.8% over the last 6 years, Molina Healthcare may not have a strong enough profitability trend to support its stock price.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 33,247,000 931,000 3 50.0
2022 31,974,000 792,000 2 0.0
2021 27,771,000 659,000 2 -33.33
2020 19,423,000 673,000 3 -25.0
2019 16,829,000 737,000 4 0.0
2018 18,890,000 707,000 4
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS